IRD 8-K: SEC filing

Opus Genetics, Inc.

Filed with the SEC on Nov 10, 2026 · accession 0001628280-26-072493

IRD filed a 8-K (current report) with the SEC on Nov 10, 2026. Opus Genetics, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2026.

Summary of the filing

Opus Genetics, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2026. The filing is an 8-K furnishing the earnings release under Item 2.02.

For details, click here →How to read a 8-K →

Key details

RegistrantOpus Genetics, Inc.

Chief executive officerDr. George Magrath

✦ Ask GOAX AI about this filing — what it means for IRD, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for IRD?

Click here

Frequently asked questions

What did IRD file with the SEC on Nov 10, 2026?

IRD filed a 8-K (SEC filing). Opus Genetics, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2026. The filing is an 8-K furnishing the earnings release under Item 2.02.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other IRD SEC filings

Get alerts when IRD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

IRD overview IRD analysis IRD news Latest SEC filings